Internal Medicine · Booneville, MS
NPI
1104236504
Since 2014
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
202 N 1st St
Booneville, MS, 38829
Phone (662) 340-1138
Groups this clinician bills Medicare through
Medicare paid, 2024
$111K
3,614 services
Medicare patients, 2024
355
Average age 77
Drug cost, 2024
$2.0M
20,399 prescriptions
Company payments, 2025
$306
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael Hancock was code 99214 (office e&m - established), 535 times for 191 patients. In total Michael Hancock billed 3,614 services in 63 codes, and Medicare paid $111K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 535 | 191 | $77.93 | $42K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 300 | 59 | $0.08 | $24.73 |
| 85025 Blood Count | Office | 294 | 142 | $7.61 | $2,237 |
| 36415 Venipuncture Blood Collection | Office | 271 | 131 | $8.65 | $2,344 |
| 80053 Clinical Chemistry | Office | 264 | 142 | $10.35 | $2,732 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 204 | 43 | $0.32 | $64.49 |
| 96372 Injection Administration | Office | 166 | 74 | $9.16 | $1,521 |
| 99309 SNF E&M | Office | 158 | 74 | $74.82 | $12K |
| 83036 Blood Count | Office | 130 | 70 | $9.52 | $1,238 |
| 80048 Clinical Chemistry | Office | 121 | 64 | $8.29 | $1,003 |
| 84439 Clinical Chemistry | Office | 93 | 56 | $8.84 | $822 |
| 84443 Clinical Chemistry | Office | 93 | 56 | $16.46 | $1,531 |
| 99308 SNF E&M | Office | 88 | 51 | $52.69 | $4,636 |
| 80061 Clinical Chemistry | Office | 83 | 74 | $13.12 | $1,089 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 80 | 16 | $0.49 | $39.48 |
By year: 2022 $104K for 3,715 services; 2023 $107K for 4,150 services; 2024 $111K for 3,614 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 294 | 142 | $7.61 | $2,237 |
| 36415 Venipuncture Blood Collection | 271 | 131 | $8.65 | $2,344 |
| 80053 Clinical Chemistry | 264 | 142 | $10.35 | $2,732 |
| 83036 Blood Count | 130 | 70 | $9.52 | $1,238 |
| 80048 Clinical Chemistry | 121 | 64 | $8.29 | $1,003 |
| 84443 Clinical Chemistry | 93 | 56 | $16.46 | $1,531 |
| 84439 Clinical Chemistry | 93 | 56 | $8.84 | $822 |
| 80061 Clinical Chemistry | 83 | 74 | $13.12 | $1,089 |
| 81003 Clinical Chemistry | 59 | 39 | $2.20 | $130 |
| 82607 Clinical Chemistry | 32 | 29 | $14.78 | $473 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael Hancock prescribed most often to Medicare patients was Atorvastatin Calcium, with 739 prescriptions and refills. In total Michael Hancock wrote 20,399 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 739 | 942 | 112 | $14K |
| Levothyroxine Sodium Generic | 571 | 741 | 94 | $4,904 |
| Pantoprazole Sodium Generic | 551 | 683 | 94 | $11K |
| Gabapentin Generic | 510 | 597 | 83 | $9,166 |
| Potassium Chloride Generic | 502 | 582 | 85 | $8,935 |
| Furosemide Generic | 501 | 581 | 93 | $2,707 |
| Trazodone Hcl Generic | 472 | 529 | 68 | $6,589 |
| Amlodipine Besylate Generic | 443 | 614 | 83 | $4,196 |
| Rosuvastatin Calcium Generic | 440 | 706 | 92 | $10K |
| Metoprolol Succinate Generic | 376 | 549 | 74 | $4,896 |
| Lisinopril Generic | 350 | 513 | 67 | $3,311 |
| Omeprazole Generic | 350 | 494 | 59 | $7,239 |
| Donepezil Hcl Generic | 329 | 379 | 55 | $8,293 |
| Eliquis Apixaban | 315 | 340 | 49 | $184K |
| Tamsulosin Hcl Generic | 310 | 404 | 58 | $4,465 |
Brand drugs: 2,916 claims; generic drugs: 17,442 claims; opioid claims: 544.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael Hancock $306 ($306 in general payments such as food, travel and fees) from 7 companies. The largest payer was Amgen Inc. with $135.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.